We describe one patient with acute Epstein-Barr virus (EBV) infection associated with severe thrombocytopenia and review 36 additional cases reported in the literature. Complications of EBV infection due to severe thrombocytopenia occurred in 10 (27.0%) of 37 patients, and 2 (5.4%) of 37 patients died. Although acute EBV infections are generally benign and self-limiting, thrombocytopenia, a potentially serious complication, should not be overlooked.
/mm 3 . We describe a case of severe thrombocytopenia in the setting of an acute EBV infection in an otherwise healthy experience bleeding or other complications. A second Monospot test was performed for which the result teenage female and review 36 additional cases in the literature to better characterize the syndrome.
was positive. EBV-specific serology was conclusive for recent infection. The titer of IgM antibody to viral capsid antigen was elevated (1:40, normal range õ1:10; EBV-VCA-IgM ELISA Case Report [Clark Laboratories , Jamestown, NY]); the titer of antibody to early antigen-diffuse was elevated (1:20, normal range õ1:10 A previously healthy, 17-year-old Caucasian female presented to University of Tennessee Medical Center at Knoxville [Gran Bio, Temecula, CA]), whereas the titer of antibody to early antigen-restricted was within the normal range (õ1:10 (Knoxville, TN) with a 2-week history of dizziness, lethargy, and fever and a 1-day history of lower-extremity petechiae.
[ . The result of a Monowere negative; a urine culture was negative for CMV, and an antinuclear antibody screen was negative as well. The patient spot test performed at that time was negative, and the patient started receiving therapy with clarithromycin.
was discharged to her home after 4 days with a platelet count of 51.0 1 10 3 /mm 3 ; she was to continue corticosteroids to be Physical examination on admission to the hospital revealed a temperature of 38.3ЊC, right tonsillar swelling and erythema, taken orally on a tapering dose. Currently, Ç2 months after onset of illness, she is well with a normal platelet count. soft-palate petechiae, and diffuse lower-extremity petechiae. Results of her initial laboratory examination were as follows: hemoglobin, 12.8 g/dL; hematocrit, 37.7%; peripheral WBC Methods and Results count, 8,200/mm 3 ; and platelet count, 4 1 10
Platelet antibody assays were done in 17 cases (46%); antibodies were detected in seven cases. The gender distribution of patients with demonstrable platelet antibodies was similar; four (40%) of 10 males and three (42.9%) of seven females had platelet antibodies.
Discussion
The etiology of severe thrombocytopenia in the setting of acute EBV infection is thought to be immune mediated [1] . Platelet antibodies were demonstrated in seven of the cases included in our review. Twenty-one of the 37 patients were not screened for antiplatelet antibodies; therefore, based on this review, it is not possible to determine the prevalence of these megaly is often demonstrated on physical examination or by radiographic or ultrasonographic procedures in patients with acute EBV infection. However, the presence of splenomegaly were negative. Sense (negative control) riboprobe did not bind in and of itself is not an indicator for the development of to any of the cell preparations.
thrombocytopenia; patients with splenomegaly can have norWe searched MEDLINE for cases of acute EBV infection mal platelet counts, and patients with profound thrombocytocomplicated by severe thrombocytopenia reported between Janpenia can have normal-sized spleens. uary 1965 and September 1996. Only cases with platelet counts To our knowledge, in situ hybridization to determine the of õ20 1 10 3 /mm 3 were considered severe thrombocytopenia presence of EBV in the bone marrow of patients with associated and included in the review. We identified 36 cases [4 -25] :
severe thrombocytopenia has not been reported previously. It these cases are reviewed together with our case from the current is tempting to speculate, because of the absence of discernible report.
EBV in the bone marrow biopsy obtained from our patient, Ages of patients ranged from 17 months to 70 years (mean that a bone marrow functional abnormality was not the primary age, 35.7 years). Twenty-eight (75.7%) of the 37 patients were cause of severe thrombocytopenia and that peripheral consump-21 years of age or younger. Sixty percent (n Å 22) of patients tion was prominent in the pathogenesis of this complication. were male. Almost two-thirds (24 of 37, 64.9%) of patients Successful treatment of EBV-associated thrombocytopenia presented with petechiae, purpura, or bruising. Twelve patients can be difficult. Corticosteroids are most often used, but im-(32.4%) developed epistaxis. Four patients had bleeding gums, and only one patient each had rectal bleeding, hemoptysis, and gross hematuria.
Twenty-nine (78.4%) of 37 patients developed platelet count nadirs õ10 1 10 Twenty-nine (78.4%) of 37 patients received corticosteroids. Nine of 10 who developed complications of thrombocytopenia and 20 (74.1%) of 27 patients who did not develop complications received corticosteroids ( P Å .2875). Platelet transfusions were given to two of 10 and 11 (40.7%) of 27 patients ( P Å .2191) who did and did not manifest complications of with and without complications, respectively.
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